- Home
- CABA vs AKA Comparison
CABA vs AKA Comparison
Compare CABA & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CABA
- AKA
- Stock Information
- Founded
- CABA 2017
- AKA 2018
- Country
- CABA United States
- AKA United States
- Employees
- CABA N/A
- AKA N/A
- Industry
- CABA Biotechnology: Biological Products (No Diagnostic Substances)
- AKA Catalog/Specialty Distribution
- Sector
- CABA Health Care
- AKA Consumer Discretionary
- Exchange
- CABA Nasdaq
- AKA Nasdaq
- Market Cap
- CABA 132.6M
- AKA 110.4M
- IPO Year
- CABA 2019
- AKA 2021
- Fundamental
- Price
- CABA $1.49
- AKA $10.42
- Analyst Decision
- CABA Strong Buy
- AKA Strong Buy
- Analyst Count
- CABA 7
- AKA 3
- Target Price
- CABA $12.43
- AKA $24.33
- AVG Volume (30 Days)
- CABA 1.3M
- AKA 5.6K
- Earning Date
- CABA 08-07-2025
- AKA 08-06-2025
- Dividend Yield
- CABA N/A
- AKA N/A
- EPS Growth
- CABA N/A
- AKA N/A
- EPS
- CABA N/A
- AKA N/A
- Revenue
- CABA N/A
- AKA $598,107,000.00
- Revenue This Year
- CABA N/A
- AKA $7.23
- Revenue Next Year
- CABA N/A
- AKA $4.04
- P/E Ratio
- CABA N/A
- AKA N/A
- Revenue Growth
- CABA N/A
- AKA 7.67
- 52 Week Low
- CABA $0.99
- AKA $7.00
- 52 Week High
- CABA $5.83
- AKA $32.25
- Technical
- Relative Strength Index (RSI)
- CABA 42.02
- AKA 41.52
- Support Level
- CABA $1.40
- AKA $10.42
- Resistance Level
- CABA $1.56
- AKA $11.35
- Average True Range (ATR)
- CABA 0.12
- AKA 0.41
- MACD
- CABA -0.01
- AKA -0.03
- Stochastic Oscillator
- CABA 20.83
- AKA 25.01
About CABA Cabaletta Bio Inc.
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.